Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morrow

Showing results (491-500 of 942) with videos related to

Pageof 95
Sort By:
Circulation|April 8, 2009
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trialDavid A Morrow, Benjamin M Scirica, Bernard R Chaitman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2007
Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery diseaseMarc S Sabatine, David A Morrow, Michelle O'Donoghue, et al.
Journal of the American Heart Association|April 22, 2021
Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50David D Berg, Benjamin L Freedman, Marc P Bonaca, et al.
Vascular Medicine (London, England)|February 1, 2020
Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trialArman Qamar, David A Morrow, Mark A Creager, et al.
Frontiers in Neurology|June 7, 2022
Models of Care in Multiple Sclerosis: A Survey of Canadian Health ProvidersRuth Ann Marrie, Sarah J Donkers, Draga Jichici, et al.
Clinical Cardiology|February 5, 2013
Prognostic evaluation of catalytic iron in patients with acute coronary syndromesDylan L Steen, Christopher P Cannon, Suhas S Lele, et al.
Clinical Chemistry and Laboratory Medicine|February 3, 2019
Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACSThomas A Zelniker, Petr Jarolim, Michael G Silverman, et al.
JAMA Cardiology|October 6, 2016
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Clinical Cardiology|January 24, 2014
Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED chest pain studyDevraj Sukul, Marc P Bonaca, Christian T Ruff, et al.
Multiple Sclerosis and Related Disorders|September 20, 2025
Machine learning using clinical variables to screen for depression and anxiety in people with early multiple sclerosisBraxton Phillips, Sarah A Morrow, Harasees Singh, et al.
Pageof 95

Showing results (491-500 of 942) with videos related to

Sort By:
Pageof 95
Circulation|April 8, 2009
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trialDavid A Morrow, Benjamin M Scirica, Bernard R Chaitman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2007
Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery diseaseMarc S Sabatine, David A Morrow, Michelle O'Donoghue, et al.
Journal of the American Heart Association|April 22, 2021
Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50David D Berg, Benjamin L Freedman, Marc P Bonaca, et al.
Vascular Medicine (London, England)|February 1, 2020
Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trialArman Qamar, David A Morrow, Mark A Creager, et al.
Frontiers in Neurology|June 7, 2022
Models of Care in Multiple Sclerosis: A Survey of Canadian Health ProvidersRuth Ann Marrie, Sarah J Donkers, Draga Jichici, et al.
Clinical Cardiology|February 5, 2013
Prognostic evaluation of catalytic iron in patients with acute coronary syndromesDylan L Steen, Christopher P Cannon, Suhas S Lele, et al.
Clinical Chemistry and Laboratory Medicine|February 3, 2019
Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACSThomas A Zelniker, Petr Jarolim, Michael G Silverman, et al.
JAMA Cardiology|October 6, 2016
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Clinical Cardiology|January 24, 2014
Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED chest pain studyDevraj Sukul, Marc P Bonaca, Christian T Ruff, et al.
Multiple Sclerosis and Related Disorders|September 20, 2025
Machine learning using clinical variables to screen for depression and anxiety in people with early multiple sclerosisBraxton Phillips, Sarah A Morrow, Harasees Singh, et al.
Pageof 95